The Antibody Drugs Effectiveness at Lower Doses

Two Eli Lilly & Co. antibody-based drugs reduced Covid-19-related hospitalizations and deaths among recently diagnosed patients when given at lower doses than previously tested, a new study found, which could help stretch supplies of the therapy. "These antibodies have a profound impact on the course of the disease," Lilly Chief Scientific Officer Daniel Skovronsky said in an interview. For the whole story check out the link right here.